Latest European patent oppositions filed by Cms Cameron Mckenna Nabarro Olswang Llp
Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3542790 | Compositions Comprising A Delivery Agent And Preparation Thereof | NOVO NORDISK A/S | 2024-06-13 |
EP3695012 | Inhibition Of Hsd17B13 In The Treatment Of Liver Disease In Patients Expressing The Pnpla3 I148M Variation | REGENERON PHARMACEUTICALS, INC. | 2023-12-08 |
EP3307872 | Methods And Compositions For Efficient Delivery Of Nucleic Acids And Rna-Based Antimicrobials | NORTH CAROLINA STATE UNIVERSITY | 2023-10-30 |
EP3199174 | Uses Of Neuregulin In Preventing, Treating Or Delaying Ventricular Arrhythmia, And Composition Thereof | ZENSUN (SHANGHAI) SCIENCE AND TECHNOLOGY, CO., LTD. | 2023-01-13 |
EP3848454 | Live Cell Constructs For Production Of Cultured Milk Product And Methods Using The Same | BIOMILQ, INC. | 2022-11-09 |
EP3636778 | Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd) | FRED HUTCHINSON CANCER CENTER | 2022-10-12 |
EP3456190 | Antibody Producing Non-Human Mammals | MERUS N.V. | 2022-08-19 |
EP3351261 | Combination Medicament Comprising Il-12 And An Agent For Blockade Of T-Cell Inhibitory Molecules For Tumour Therapy | UNIVERSITÄT ZÜRICH | 2022-03-02 |
EP3247808 | Point-Of-Care And/Or Portable Platform For Gene Therapy | FRED HUTCHINSON CANCER RESEARCH CENTER | 2022-02-03 |
EP3626819 | Transgenic Mouse Which Produces Hybrid Antibodies Containing Human Variable Regions And Mouse Constant Regions | REGENERON PHARMACEUTICALS, INC. | 2021-12-22 |
Top clients of Cms Cameron Mckenna Nabarro Olswang Llp filing patent oppositions